Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Regadenoson R-T Perfusion Imaging Trial

This study has been completed.
Sponsor:
Collaborators:
Mayo Clinic
Astellas Pharma Inc
Information provided by (Responsible Party):
Thomas R. Porter, MD, University of Nebraska
ClinicalTrials.gov Identifier:
NCT00837369
First received: February 3, 2009
Last updated: July 19, 2012
Last verified: July 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2011
  Primary Completion Date: March 2011 (Final data collection date for primary outcome measure)